Fig. 1From: Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patientsRepresentative images for the 0, 1+, 2+, and 3+ intensities of HER2 expression on CTCsBack to article page